Small Molecules, Biologics
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
91
NCT05947474
ORB-011 In Patients With Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 21, 2023
Completion: Dec 31, 2025
NCT06607939
ORB-021 In Patients With Advanced Solid Tumors
Start: Nov 21, 2024
Completion: Feb 28, 2027
Loading map...